Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS AND VIEWS

Natural killer cells lull tumours into dormancy

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Nature 594, 501-502 (2021)

doi: https://doi.org/10.1038/d41586-021-01381-5

References

  1. Mohme, M., Riethdorf, S. & Pantel, K. Nature Rev. Clin. Oncol. 14, 155–167 (2017).

    PubMed  Article  Google Scholar 

  2. Correia, A. et al. Nature 594, 566–571 (2021).

    Article  Google Scholar 

  3. Chiossone, L., Dumas, P.-Y., Vienne, M. & Vivier, E. Nature Rev. Immunol. 18, 671–688 (2018).

    PubMed  Article  Google Scholar 

  4. Daher, M. & Rezvani, K. Cancer Discov. 11, 45–58 (2021).

    PubMed  Article  Google Scholar 

  5. Myers, J. A. & Miller, J. S. Nature Rev. Clin. Oncol. 18, 85–100 (2021).

    PubMed  Article  Google Scholar 

  6. López-Soto, A., Gonzalez, S., Smyth, M. J. & Galluzzi, L. Cancer Cell 32, 135–154 (2017).

    PubMed  Article  Google Scholar 

  7. Molgora, M. et al. Nature 551, 110–114 (2017).

    PubMed  Article  Google Scholar 

  8. Malladi, S. et al. Cell 165, 45–60 (2016).

    PubMed  Article  Google Scholar 

  9. Tsuchida, T. & Friedman, S. L. Nature Rev. Gastroenterol. Hepatol. 14, 397–411 (2017).

    PubMed  Article  Google Scholar 

  10. Shi, Y., Riese, D. J., 2nd & Shen, J. Front. Pharmacol. 11, 574667 (2020).

    PubMed  Article  Google Scholar 

  11. Dadi, S. et al. Cell 164, 365–377 (2016).

    PubMed  Article  Google Scholar 

  12. Gao, Y. et al. Nature Immunol. 18, 1004–1015 (2017).

    PubMed  Article  Google Scholar 

  13. Gauthier, L. et al. Cell. 177, 1701–1713 (2019).

    PubMed  Article  Google Scholar 

Download references

Competing Interests

E.V. is a shareholder and employee of Innate Pharma.

Subjects

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links